Crosstalk Between the Heart and Cancer: Beyond Drug Toxicity
- PMID: 32804565
- PMCID: PMC7436939
- DOI: 10.1161/CIRCULATIONAHA.120.048655
Crosstalk Between the Heart and Cancer: Beyond Drug Toxicity
Keywords: Editorials; cardiology; models, animal; neoplasms.
Conflict of interest statement
Conflict of Interest/Disclosures
JM has served on advisory boards for Pfizer, Novartis, Bristol-Myers Squibb, Deciphera, Audentes Pharmaceuticals, Nektar, Ipsen, Takeda, Myokardia, AstraZeneca, TripleGene/Precisgen, Regeneron GlaxoSmithKline, Boston Biomedical, ImmunoCore, Janssen, and Myovant and is supported by R01 HL141466. QZ is a Cancer Prevention and Research Institute of Texas (CPRIT) Scholar and is supported by CPRIT (RR190058) and NCI R01CA211732. KJM is supported by the National Institutes of Health (R35HL135799 and P01HL131478).
Figures
Comment on
-
Early Cardiac Remodeling Promotes Tumor Growth and Metastasis.Circulation. 2020 Aug 18;142(7):670-683. doi: 10.1161/CIRCULATIONAHA.120.046471. Epub 2020 Jun 1. Circulation. 2020. PMID: 32475164
References
-
- Moslehi JJ. Cardiovascular Toxic Effects of Targeted Cancer Therapies. N Engl J Med. 2016;375:1457–1467. - PubMed
-
- Meijers WC, Maglione M, Bakker SJL, Oberhuber R, Kieneker LM, de Jong S, Haubner BJ, Nagengast WB, Lyon AR, van der Vegt B, et al. Heart Failure Stimulates Tumor Growth by Circulating Factors. Circulation. 2018;138:678–691. - PubMed
-
- Avraham S, Abu-Sharki S, Shofti R, Haas T, Korin B, Kalfon R, Friedman T, Shiran A, Saliba W, Shaked Y and Aronheim A. Early Cardiac Remodeling Promotes Tumor Growth and Metastasis. Circulation. 2020[In Press]. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
